News

November 19, 2019 — Since Maquet/Datascope first recalled all of its intra-aortic balloon pumps (IABP) due to reports of ...

Home November 19, 2019
Home
The American Heart Association, AHA, 2019 meeting late breaking trials and key studies on cardiovascular science.
Feature | AHA | Dave Fornell, Editor

Here is a list of the key late-breaking clinical study presentations at the 2019 American Heart Association (AHA) annual meeting, Nov. 16-18, 2019, in Philadelphia.

Home November 19, 2019
Home
News | Pacemakers

(February 2020 update — the results of this trial led to the FDA clearnace of the Micra AV device in January 2020 - FDA ...

Home November 15, 2019
Home
News | Deep Vein Thrombosis (DVT)

November 7, 2019 — The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following ...

Home November 14, 2019
Home
News | Peripheral Artery Disease (PAD)

November 7, 2019 — Ultrasoundplasty before angioplasty for below-the-knee lesions (BTK) lesions may improve clinical ...

Home November 14, 2019
Home
News | Peripheral Artery Disease (PAD)

November 14, 2019 — There were positive results in the TANGO Trial is a phase 2, dose escalation, double-blinded trial ...

Home November 14, 2019
Home
News | AHA

November 14, 2019 — More than a million Americans face a doubling in their risk of death during or while recovering from ...

Home November 14, 2019
Home
News | AHA

November 14, 2019 — A new study from researchers at the Smidt Heart Institute at Cedars-Sinai shows that electronic ...

Home November 14, 2019
Home
News | Peripheral Artery Disease (PAD)

November 14, 2019 — Results were positive for the multicenter PROMISE I Trial represents the first human use in the ...

Home November 14, 2019
Home
News | AHA

November 14, 2019 — A large majority of patients with atherosclerotic cardiovascular disease (ASCVD) in the NCDR ...

Home November 14, 2019
Home
News | Drug-Eluting Balloons

November 7, 2019 — The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the ...

Home November 14, 2019
Home
Viva conference late breaking clinical trials, #VIVA19 #VIVA #VIVA2019
Feature | VIVA

November 14, 2019 — The results of the 21 late-breaking clinical trials presented for the first time at Vascular ...

Home November 14, 2019
Home
News | Cardiovascular Ultrasound

November 14, 2019 — Ultromics has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...

Home November 14, 2019
Home
News | Pacemakers

https://www.dicardiology.com/channel/pacemakersTexas Heart Institute (THI) was awarded a prestigious four-year, $2.39 million grant from the National Institutes of Health (NIH) to explore further the development of a novel pacemaker system that is both leadless and wirelessly powered.

Home November 13, 2019
Home
Subscribe Now